BANK VONTOBEL/CALL/MERCK & CO./125/0.1/20.12.24 Stock

Warrant

DE000VD3SE89

Market Closed - Boerse Frankfurt Warrants 13:50:58 2024-05-20 EDT
1.21 EUR +2.54% Intraday chart for BANK VONTOBEL/CALL/MERCK & CO./125/0.1/20.12.24
Current month+0.83%
1 month+17.48%
Date Price Change
24-05-20 1.21 +2.54%
24-05-17 1.18 -0.84%
24-05-16 1.19 -2.46%
24-05-15 1.22 +18.45%
24-05-14 1.03 -1.90%

Real-time Boerse Frankfurt Warrants

Last update May 20, 2024 at 01:50 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VD3SE8
ISINDE000VD3SE89
Date issued 2024-04-09
Strike 125 $
Maturity 2024-12-20 (214 Days)
Parity 10 : 1
Emission price 1.04
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.35
Lowest since issue 0.95
Spread 0.01
Spread %0.84%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.2 USD
Average target price
141.6 USD
Spread / Average Target
+7.96%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW